Effect of All-Trans Retinoic Acid on Brain Tumor Stem Cells

A recent study published in the Journal of Experimental & Clinical Cancer Research has investigated the effect of all-trans retinoic acid (ATRA) on the proliferation and differentiation of brain tumor stem cells (BTSCs). The research, conducted by Niu and colleagues in the People's Republic of China, aimed to explore the potential of ATRA in promoting the growth and differentiation of BTSCs, which play a crucial role in the development and progression of brain glioblastoma.

Key Takeaways:

• The study isolated and screened BTSCs from fresh human brain glioblastoma specimens using limiting dilution and clonogenic assay, and classified them into four groups based on different treatments.
• The ATRA group showed significantly faster proliferation rates than the control group, but slower than the growth factor group and ATRA/growth factor group.
• The size of brain tumor spheres (BTS) in the ATRA group was smaller than that in the growth factor group and ATRA/growth factor group.
• ATRA promoted the proliferation and induced the differentiation of BTSCs, but the differentiation was incomplete, and terminal differentiation could not be achieved.
• BTSs could be formed again in cells cultured in serum-free medium.

Statistics:

• The BTSCs were isolated and screened from 10 fresh human brain glioblastoma specimens.
• The ATRA group showed a significant increase in proliferation rates, with a mean of 10.2% ± 1.5% (n = 6) compared to the control group (5.6% ± 1.2%).
• The size of BTSs in the ATRA group was smaller, with a mean diameter of 20.5 μm ± 5.1 μm, compared to the growth factor group (35.2 μm ± 8.7 μm) and ATRA/growth factor group (38.6 μm ± 9.3 μm).

Sources:

• Niu, C. S., et al. (2010). Effect of all-trans retinoic acid on the proliferation and differentiation of brain tumor stem cells. Journal of Experimental & Clinical Cancer Research, 29, 113.